We are live on
!
Find out more
SM
SG3 Management Portfolio holdings
AUM
$6.45K
1-Year Est. Return
61.81%
This Fund
S&P 500
This Quarter
Est. Return
+9.09%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
–
AUM
$4B
AUM Growth
-$1.25B
(-24%)
Cap. Flow
-$1.28B
Cap. Flow
% of AUM
-32.02%
Top 10 Holdings %
Top 10 Hldgs %
20.82%
Holding
1,612
New
626
Increased
195
Reduced
208
Closed
487
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$10.2M |
| 2 |
PARA
Paramount Global Class B
PARA
|
+$6.08M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$5.95M |
| 4 |
Biogen
BIIB
|
+$5.94M |
| 5 |
Aon
AON
|
+$5.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$294M |
| 2 |
Lennar Class A
LEN
|
+$76.3M |
| 3 |
RH
RH
|
+$25.1M |
| 4 |
ARK Genomic Revolution ETF
ARKG
|
+$22.5M |
| 5 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$22.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 1.79% |
| 2 | Communication Services | 1.57% |
| 3 | Technology | 1.13% |
| 4 | Consumer Discretionary | 1.05% |
| 5 | Financials | 0.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ETWO
251
CALL
DELISTED
E2open Parent Holdings
ETWO
| $3.71M | 0.09% |
+372,500
| New | +$3.81M |
|
|
ONIT
252
PUT
Onity Group
ONIT
$315M
| $3.7M | 0.09% |
130,000
| – | – |
|
253
CALL
Atlassian
TEAM
$24.9B
| $3.69M | 0.09% |
+17,500
| New | +$4.07M |
|
254
PUT
Arrowhead Research
ARWR
$12.3B
| $3.65M | 0.09% |
+55,000
| New | +$4.27M |
|
255
Camping World
CWH
$400M
| $3.64M | 0.09% |
100,000
+90,000
| +900% | +$3.2M |
|
256
CALL
iQIYI
IQ
$1.24B
| $3.62M | 0.09% |
218,000
+33,000
| +18% | +$762K |
|
257
Texas Instruments
TXN
$255B
| $3.59M | 0.09% |
19,000
+17,000
| +850% | +$2.95M |
|
258
PUT
Microsoft
MSFT
$3.35T
| $3.58M | 0.09% |
+15,200
| New | +$3.53M |
|
259
argenx
ARGX
$54.6B
| $3.58M | 0.09% |
+13,000
| New | +$4.11M |
|
260
CALL
Exelon
EXC
$46.6B
| $3.56M | 0.09% |
+114,123
| New | +$3.43M |
|
261
CALL
Lyft
LYFT
$5.9B
| $3.54M | 0.09% |
56,000
| – | – |
|
262
CALL
Lucid Motors
LCID
$3.17B
| $3.54M | 0.09% |
+15,260
| New | +$4.08M |
|
263
CALL
PNC Financial Services
PNC
$99.2B
| $3.51M | 0.09% |
20,000
+17,200
| +614% | +$2.84M |
|
264
CALL
Paysafe
PSFE
$434M
| $3.48M | 0.09% |
+21,467
| New | +$3.48M |
|
265
CALL
CVS Health
CVS
$134B
| $3.47M | 0.09% |
46,100
-24,100
| -34% | -$1.76M |
|
266
PUT
Eli Lilly
LLY
$1.03T
| $3.46M | 0.09% |
+18,500
| New | +$3.62M |
|
267
PUT
Pool Corp
POOL
$6.95B
| $3.45M | 0.09% |
+10,000
| New | +$3.48M |
|
|
ALLK
268
CALL
DELISTED
Allakos
ALLK
| $3.44M | 0.09% |
+30,000
| New | +$3.79M |
|
|
ALLK
269
PUT
DELISTED
Allakos
ALLK
| $3.44M | 0.09% |
+30,000
| New | +$3.79M |
|
|
RUBY
270
PUT
DELISTED
Rubius Therapeutics, Inc
RUBY
| $3.44M | 0.09% |
+129,800
| New | +$1.9M |
|
|
BHVN
271
PUT
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $3.42M | 0.09% |
50,000
-33,400
| -40% | -$2.7M |
|
272
PUT
BioMarin Pharmaceuticals
BMRN
$11.7B
| $3.4M | 0.08% |
45,000
-144,800
| -76% | -$11.8M |
|
273
PUT
iShares MSCI Brazil ETF
EWZ
$9.25B
| $3.35M | 0.08% |
+100,000
| New | +$3.46M |
|
274
PUT
QuantumScape Corp
QS
$3.22B
| $3.31M | 0.08% |
74,000
+50,000
| +208% | +$2.62M |
|
275
PUT
Fate Therapeutics
FATE
$293M
| $3.3M | 0.08% |
40,000
+30,000
| +300% | +$2.87M |
|
Similar funds
EAM
CAM
CCM
GPCM
MAM
BGCI
TPL
RC
SG3 Management's Q1 2021 Portfolio in Review
As of Q1 2021, SG3 Management held 1,612 positions worth $4B, down 24% from $5.25B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
SG3 Management withdrew a net $1.28B in Q1 2021, closing 487 positions and reducing 208 holdings. Its most notable exit was Amazon, an estimated $294M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 1.8% of assets, up from 0.67% a quarter earlier, followed by Communication Services and Technology.
Against the trend, SG3 Management opened a new position in Albemarle worth $4.16M.
- SG3 Management's largest Q1 2021 buy was Albemarle: 28,500 shares worth $4.16M.
- SG3 Management added most to Jazz Pharmaceuticals in Q1 2021, an estimated $10.2M increase.
- SG3 Management's biggest Q1 2021 reduction was RH, cutting an estimated $25.1M.
- SG3 Management fully exited Amazon in Q1 2021, selling an estimated $294M.
- SG3 Management's ten largest holdings make up 21% of its $4B portfolio in Q1 2021.
- SG3 Management opened 626 new positions and closed 487 in Q1 2021.
- SG3 Management's portfolio value fell 24% quarter-over-quarter to $4B.
Based on SG3 Management's 13F filing for Q1 2021, filed 17 May 2021.